31 – 40 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced Dyskinesia
- Contribution to journal › Article
-
Mark
Novel insights regarding the measurement properties of the SCOPA-AUT
- Contribution to journal › Article
-
Mark
Association between Parkinson’s Disease and Diabetes Mellitus : From Epidemiology, Pathophysiology and Prevention to Treatment
- Contribution to journal › Article
- 2021
-
Mark
The bacterial amyloids phenol soluble modulins from staphylococcus aureus catalyze alpha-synuclein aggregation
- Contribution to journal › Article
-
Mark
Postmortem Studies of Fetal Grafts in Parkinson’s Disease : What Lessons Have We Learned?
- Contribution to journal › Scientific review
-
Mark
Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
- Contribution to journal › Article
-
Mark
Personalised advanced therapies in parkinson’s disease : The role of non-motor symptoms profile
- Contribution to journal › Article
-
Mark
The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
- Contribution to journal › Article
-
Mark
High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease
- Contribution to journal › Article
-
Mark
Genetically targeted clinical trials in parkinson’s disease : Learning from the successes made in oncology
- Contribution to journal › Scientific review
